An attempt to define sets of cooperating genetic alterations in human breast cancer.
The extent and the variation of losses of genetic material were examined in a series of 191 human breast cancers by means of a set of 18 polymorphic DNA probes, specific of 7 chromosomal arms (1p, 1q, 3p, 11p, 13q, 17p and 18q) known to be frequently affected by allele losses. Frequencies of losses of heterozygosity ranged from a low of 3.5% (chromosome 13q) to a high of 27% (chromosome 3p). The number of sites involved in breast cancer added to the frequent occurrence of concomitant losses at several chromosomal arms within the same tumor suggest cooperative effects of these LOHs. We were therefore interested in assessing the existence of preferential associations between sets of LOHs in our panel of tumors. Statistically significant associations were found between LOHs at chromosomes 1p and 17p, and between LOHs at chromosomes 11p and 17p. Furthermore, since all the tumors presently studied had previously been analyzed for proto-oncogene amplification at 5 distinct chromosomal sites, we tested for associations between LOH and DNA amplification. Such associations were indeed observed as exemplified by the correlations observed between the LOH at 11p and amplification of the erbB2 gene and LOH at 17p and the amplification of the flg gene. The only correlation with clinico-pathological parameters that could be observed linked the occurrence of LOHs on 11p with recurrent breast cancer (p = 0.015). Sets of several LOHs or LOHs and gene amplifications could not be significantly related to any marker of tumor aggressiveness.
CNRS URA 1191, Laboratoire de Biologie Moléculaire Université des Sciences et des Techniques du Languedoc, Montpellier, France.
M B
MB
Cheickh
P
P
Rouanet
G
G
Louason
P
P
Jeanteur
C
C
Theillet
D001943:Breast Neoplasms / Q000235:genetics* / Q000473:pathology; D015342:DNA Probes; D004273:DNA, Neoplasm / Q000032:analysis*; D000091344:Filaggrin Proteins; D005784:Gene Amplification; D006579:Heterozygote; D006801:Humans; D009361:Neoplasm Invasiveness / Q000235:genetics; D009364:Neoplasm Recurrence, Local / Q000235:genetics; D012150:Polymorphism, Restriction Fragment Length; D000090063:Proto-Oncogene Mas
D015342:DNA Probes; D004273:DNA, Neoplasm; C000717249:FLG protein, human; D000091344:Filaggrin Proteins; C000715470:MAS1 protein, human; D000090063:Proto-Oncogene Mas